XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Common stock, shares outstanding, beginning balance (in shares) at Jan. 31, 2022   334,760,615      
Beginning balance at Jan. 31, 2022 $ 547,014 $ 33 $ 1,366,855 $ (8,219) $ (811,655)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under stock plans, net of tax withholding (in shares)   1,631,104      
Issuance of common stock under stock plans, net of tax withholding 773 $ 1 772    
Issuance of common stock upon exercise of warrants (in shares)   16,948      
Issuance of common stock upon exercise of warrants 48   48    
Issuance of common stock upon ESPP purchase (in shares)   263,962      
Issuance of common stock upon ESPP purchase 3,920   3,920    
Vesting of early exercised stock options 17   17    
Stock-based compensation 15,527   15,527    
Net loss (89,266)       (89,266)
Other comprehensive income (loss) (12,941)     (12,941)  
Common stock, shares outstanding, ending balance (in shares) at Apr. 30, 2022   336,672,629      
Ending balance at Apr. 30, 2022 $ 465,092 $ 34 1,387,139 (21,160) (900,921)
Common stock, shares outstanding, beginning balance (in shares) at Jan. 31, 2023 348,330,481 348,330,481      
Beginning balance at Jan. 31, 2023 $ 354,992 $ 35 1,528,104 (16,384) (1,156,763)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock under stock plans, net of tax withholding (in shares)   2,278,764      
Issuance of common stock under stock plans, net of tax withholding 915   915    
Issuance of common stock upon ESPP purchase (in shares)   562,829      
Issuance of common stock upon ESPP purchase 4,875   4,875    
Issuance of common stock in connection with ATM offerings, net of issuance costs (in shares)   1,909,028      
Issuance of common stock in connection with ATM offerings, net of issuance costs 17,516   17,516    
Vesting of early exercised stock options 14   14    
Stock-based compensation 23,964   23,964    
Net loss (79,388)       (79,388)
Other comprehensive income (loss) $ 4,591     4,591  
Common stock, shares outstanding, ending balance (in shares) at Apr. 30, 2023 353,081,102 353,081,102      
Ending balance at Apr. 30, 2023 $ 327,479 $ 35 $ 1,575,388 $ (11,793) $ (1,236,151)